Sat, 14 November 2015
Are Immune Checkpoint Inhibitors Sufficiently Tolerable to Recommend Them for Older or More Frail Patients?
Drs. Ben Solomon, Leora Horn, & Jack West consider whether immunotherapy might prove to be more problematic when given to a broader population of older and frail patients with advanced lung cancer.
Direct download: GRACEcast-396_WCLC_2015_Immune_Checkpoint_Inhibitor_Tolerability_Older_Frail_Patients.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT